Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: A propensity score matching study-Reference-Cited by-同舟云学术

Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: A propensity score matching study

Published:2013-03-21 Issue:4 Volume:14 Page:181-190
ISSN:1751-2972
Container-title:Journal of Digestive Diseases
language:en
Short-container-title:Journal of Digestive Diseases

Author:

Bai Wei¹,Wang Yong Ji²,Zhao Yan¹,Qi Xing Shun¹,Yin Zhan Xin¹,He Chuang Ye¹,Li Rui Jun¹,Wu Kai Chun³,Xia Jie Lai²,Fan Dai Ming³,Han Guo Hong¹

Affiliation:

1. Department of Digestive Interventional Radiology; Xijing Hospital of Digestive Diseases; Fourth Military Medical University; Xi'an; Shaanxi Province; China

2. Department of Medical Statistics; Fourth Military Medical University; Xi'an; Shaanxi Province; China

3. State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases; Fourth Military Medical University; Xi'an; Shaanxi Province; China

Publisher

Wiley

Subject

Gastroenterology

Reference34 articles.

1. Global cancer statistics in the year 2000;Parkin;Lancet Oncol,2001

2. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis;El-Serag;Gastroenterology,2007

3. Treatment modalities for hepatocellular carcinoma;Hung;Curr Cancer Drug Targets,2005

4. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma;Lo;Hepatology,2002

5. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial;Llovet;Lancet,2002

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transarterial chemoembolization with 125I seed insertion for multifocal hepatocellular carcinoma;Frontiers in Oncology;2024-04-15

2. Comparative efficacy and safety of molecular targeted agents combined with transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a network meta-analysis;Frontiers in Oncology;2023-05-17

3. Transarterial chemoembolization (TACE) plus tyrosine kinase inhibitors versus TACE in patients with hepatocellular carcinoma: a systematic review and meta-analysis;World Journal of Surgical Oncology;2023-03-31

4. Effectiveness of c-TACE Combined With Sorafenib Versus c-TACE Monotherapy in Advanced Hepatocellular Carcinoma: A Retrospective Study;Clinical Medicine Insights: Oncology;2023-01

5. External radiotherapy combined with sorafenib has better efficacy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis;Clinical and Experimental Medicine;2022-12-10